Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders – A systematic review and meta-analysis.

MLA

Murphy, Jennifer, et al. “Associations between Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Concentration and Psychiatric Disorders – A Systematic Review and Meta-Analysis.” Brain, Behavior & Immunity, vol. 120, Aug. 2024, pp. 327–38. EBSCOhost, https://doi.org/10.1016/j.bbi.2024.06.003.

APA

Murphy, J., Zierotin, A., Mongan, D., Healy, C., Susai, S. R., O’Donoghue, B., Clarke, M., O’Connor, K., Cannon, M., & Cotter, D. R. (2024). Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders – A systematic review and meta-analysis. Brain, Behavior & Immunity, 120, 327–338. https://doi.org/10.1016/j.bbi.2024.06.003

Chicago

Murphy, Jennifer, Anna Zierotin, David Mongan, Colm Healy, Subash R. Susai, Brian O’Donoghue, Mary Clarke, Karen O’Connor, Mary Cannon, and David R. Cotter. 2024. “Associations between Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Concentration and Psychiatric Disorders – A Systematic Review and Meta-Analysis.” Brain, Behavior & Immunity 120 (August): 327–38. doi:10.1016/j.bbi.2024.06.003.